Bioadaptives, Inc.Bioadaptives, Inc.Bioadaptives, Inc.

Bioadaptives, Inc.

No trades
No trades

Compare with Bioadaptives, Inc.


Market capitalization
‪19.21 K‬USD
−0.1314USD
‪−1.56 M‬USD
‪18.28 K‬USD
‪11.99 M‬
Beta (1Y)
−4.49
Employees (FY)
1
Change (1Y)
0
Revenue / Employee (1Y)
‪18.28 K‬USD
Net income / Employee (1Y)
‪−1.56 M‬USD

Profile


Sector
CEO
James Keener
Headquarters
Las Vegas
Founded
2013
IPO date
Jul 9, 2014
ISIN
US09072U2069
CUSIP
09072U206
FIGI
BBG005NLFMC8
Identifiers
ISIN US09072U2069
BioAdaptives, Inc. engages in marketing, investigating, and distributing natural plant and algal-based products that improve health and wellness for humans and animals. The company was founded on April 19, 2013 and is headquartered in Las Vegas, NV.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of BDPT is 0.0016 USD — it has increased by 11.89% in the past 24 hours. Watch Bioadaptives, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bioadaptives, Inc. stocks are traded under the ticker BDPT.
BDPT stock has fallen by −15.79% compared to the previous week, the month change is a −59.49% fall, over the last year Bioadaptives, Inc. has showed a −87.88% decrease.
BDPT reached its all-time high on Jul 11, 2014 with the price of 1,057.5000 USD, and its all-time low was 0.0008 USD and was reached on Jul 13, 2026. View more price dynamics on BDPT chart.
See other stocks reaching their highest and lowest prices.
BDPT stock is 83.33% volatile and has beta coefficient of −4.49. Track Bioadaptives, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bioadaptives, Inc. there?
Today Bioadaptives, Inc. has the market capitalization of ‪32.42 K‬, it has increased by 23.08% over the last week.
Yes, you can track Bioadaptives, Inc. financials in yearly and quarterly reports right on TradingView.
BDPT net income for the last quarter is ‪−111.09 K‬ USD, while the quarter before that showed ‪−823.35 K‬ USD of net income which accounts for 0.00% change. Track more Bioadaptives, Inc. financial stats to get the full picture.
No, BDPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 22, 2026, the company has 1 employees. See our rating of the largest employees — is Bioadaptives, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bioadaptives, Inc. EBITDA is ‪−981.74 K‬ USD, and current EBITDA margin is ‪−5.66 K‬%. See more stats in Bioadaptives, Inc. financial statements.
Like other stocks, BDPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioadaptives, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioadaptives, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioadaptives, Inc. stock shows the sell signal. See more of Bioadaptives, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.